Results of a recent French study show that multiple myeloma patients with the chromosomal abnormality t(4;14) have a high response rate after stem cell transplantation, but continue to have poor overall survival and short remission times.

Compared to conventional chemotherapy, stem cell transplantation helped the patients with t(4;14) achieve higher-quality responses. However, most patients continued to experience quick and aggressive relapses after stem cell transplantation.

The study authors indicated the need for investigation into consolidation and maintenance strategies that would slow down the rapidity and severity of relapses after remission.

Approximately 15 …